Results 271 to 280 of about 97,848 (354)

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Restrictive fluid management with early de-escalation versus usual care in critically ill patients (reduce trial): a feasibility randomized controlled trial. [PDF]

Crit Care
Naorungroj T, Prajantasen U, Sanla-Ead T, Viarasilpa T, Tongyoo S.   +4 more
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Septic Shock Due to Chyme Recycling in an Extremely Low-Birth-Weight Infant. [PDF]

Cureus
Kitamura K, Zuiki M, Imai T, Aoi S, Komatsu H.   +4 more
europepmc   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Refractory Acute Myocardial Infarction Cardiogenic Shock Due to Left Ventricular Outflow Tract Obstruction. [PDF]

JACC Case Rep
Akinmolayemi O, Beerkens FJ, Hu V, Sharma A, Feinman J, Ali SZ, Goel S, Serrao GW, Goldman ME, Lala A.   +9 more
europepmc   +1 more source

Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support

ESC Heart Failure, EarlyView.
Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai, Smit Paghdar, Jose Ruiz, Ji‐Min Jang, Sharan Malkani, Daniel S. Yip, Juan Leoni, Jose Nativi, Basar Sareyyupoglu, Kevin Landolfo, Si Pham, Parag Patel, Rohan Goswami   +12 more
wiley   +1 more source

Neuropsychiatric outcomes in sepsis: A vital sign worth monitoring. [PDF]

World J Psychiatry
Middleton ML, Lucke-Wold B.
europepmc   +1 more source

Right ventricle to pulmonary artery coupling as a prognostic factor in tricuspid regurgitation: A systematic review

ESC Heart Failure, EarlyView.
The TAPSE/SPAP ratio is associated with worse prognosis in patients with significant tricuspid regurgitation and could indicate at‐risk patients. The exact cutoff value for RV‐PA uncoupling remains difficult to define and in available studies ranged from 0.26 to 0.49 mm/mmHg.
Adam Piasecki, Adam Rdzanek, Piotr Scisło, Ewa Pędzich, Agnieszka Kapłon‐Cieślicka, Mariusz Tomaniak   +5 more
wiley   +1 more source